Valeant Pharmaceuticals International Inc $123.70

up +0.17


29/7/2014 04:00 PM  |  NYSE : VRX  
Industries : Drugs / Drug Delivery & Accessories
Get Trend Analysis Icon Get VRX Trend Analysis - it has outperformed the S&P 500 by 15%

Partner Headlines

  1. Diamond Hill Capital Comments on Valeant Pharmaceuticals International ...

    GuruFocus
  2. BTIG: Valeant Must Sweeten Allergan Bid To More Than $200/Share

    Benzinga
  3. Allergan EPS Gains Accelerate

    IBD
  4. Allergan Earnings Growth, Job Cuts Counter Valeant

    IBD
  5. UPDATE: Valeant Complains to SEC Regarding Allergan Claims

    Benzinga
  6. Valeant Submits HSR Filing Related to Proposed Allergan Deal

    Benzinga
  7. Benzinga's M&A Chatter for Wednesday July 9, 2014

    Benzinga
  8. Aegis Capital Believes Valeant Pharmaceuticals' Bid For Allergan Is Looking ...

    Benzinga
  9. Chipotle, Keurig Near Buy Points; Energy Dominates

    IBD
  10. Auxilium Acquiring QLT For New Products, Low Taxes

    IBD
  11. Benzinga's M&A Chatter for Wednesday June 25, 2014

    Benzinga
  12. Paulson builds Allergan stake

    IBD
  13. Rumor: Big Stake In Allergan Acquired By Valeant Supporter Paulson

    Benzinga
  14. Markets Close Higher Despite A Contraction In GDP

    Benzinga
  15. Benzinga's M&A Chatter for Tuesday June 24, 2014

    Benzinga
  16. Indexes Mixed As Stocks Pare Earlier Gains

    IBD
  17. Walgreen Falls On Weak Earnings, Alliance Boots Reset

    IBD
  18. 'Merger Monday' Deals, Offers And Rejections

    Benzinga
  19. Allergan Rebuffs Valeant's Tender Offer

    FoxBusiness
  20. Akorn

    IBD
  21. Akorn Shares Gaining On $41 Million Sale Of Branded Drugs Unit To Valeant

    Benzinga
  22. Shire Rejects AbbVie's $46 Bil Tax-Inversion Attempt

    IBD
  23. Valeant launches hostile bid

    IBD
  24. M&A Activity Helps Fuel Healthy Action In Drugmakers

    IBD
  25. Benzinga's M&A Chatter for Wednesday June 18, 2014

    Benzinga
  26. 5-Star Biotech Stock Watch: Synta Pharmaceuticals

    Benzinga
  27. Stocks Meander As Fed Announcement Looms

    IBD
  28. Air Products Soars As CEO Pick Suggests Asset Sales

    IBD
  29. Valeant Goes For Allergan; Analyst Touts Shire Option

    IBD
  30. Allergan, Actavis Top Big Cap Pharmas Amid M&A Flurry

    IBD
  31. Valeant shifts takeover tactics

    IBD
  32. Global M&A Up 73% To $1.6 Trillion; Health, Media Top

    IBD
  33. Valeant Pharmaceuticals

    IBD
  34. Shire Up On Report It Proactively Hired Investment Bank

    Benzinga
  35. Allergan rebuffs Valeant again

    IBD
  36. Benzinga's M&A Chatter for Tuesday June 10, 2014

    Benzinga
  37. Major Averages Fall Modestly; Facebook Bucks Trend

    IBD
  38. Stocks Hold Mild Losses; B/E Aerospace Slides

    IBD
  39. Allergan Turns Down Valeant Bid

    FoxBusiness
  40. Valeant Pharma

    IBD
  41. Ackman Explains Valeant Bid, Makes Up with Carl Icahn

    GuruFocus
  42. Several IBD 50 Names Set Up In Stock Picker's Market

    IBD
  43. Allergan May Get Higher Bid

    IBD
  44. Valeant Plans to Improve Offer for Allergan

    FoxBusiness
  45. Valeant Pharmaceuticals Responds to Allergan's Rejection of Merger Proposal

    Benzinga
  46. Allergan Rejects Valeant Bid

    IBD
  47. Benzinga's M&A Chatter for Monday May 12, 2014

    Benzinga
  48. Valeant Stock Moves Little As Takeover Bid Rejected

    IBD
  49. Leaderboard Is Educational, Informative, Actionable

    IBD
  50. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
Trading Center